SitesBLAST
Comparing AO356_09010 FitnessBrowser__pseudo5_N2C3_1:AO356_09010 to proteins with known functional sites using BLASTp with E ≤ 0.001.
Or try Sites on a Tree, PaperBLAST, Conserved Domains, or compare to all protein structures
Found 20 (the maximum) hits to proteins with known functional sites (download)
P07117 Sodium/proline symporter; Proline carrier; Proline permease; Propionate transporter from Escherichia coli (strain K12) (see 4 papers)
75% identity, 99% coverage: 1:491/494 of query aligns to 1:492/502 of P07117
- R257 (= R257) mutation to C: Sodium-independent binding affinity for proline.
- C281 (= C281) mutation to S: Does not affect proline uptake activity. Confers resistance to N-ethylmaleimide. Na(+)-dependent proline binding activity is similar to wild-type carrier.
- C344 (= C344) mutation to S: Small decrease in proline uptake activity. Confers resistance to N-ethylmaleimide. Exhibits low Na(+)-dependent proline binding.
- C349 (= C349) mutation to S: Does not affect proline uptake activity. Sensitive to N-ethylmaleimide. Na(+)-dependent proline binding activity is similar to wild-type carrier.
- R376 (= R376) mutation R->E,Q: No change in activity.; mutation to K: Loss of activity.
Q9ET37 Solute carrier family 5 member 4A; SGLT3-a from Mus musculus (Mouse) (see paper)
24% identity, 87% coverage: 12:439/494 of query aligns to 33:494/656 of Q9ET37
- E457 (≠ A406) mutation to Q: Confers sodium-dependent sugar transport activity not found in the wild type protein.
Q9NY91 Probable glucose sensor protein SLC5A4; Solute carrier family 5 member 4 from Homo sapiens (Human) (see paper)
23% identity, 86% coverage: 12:437/494 of query aligns to 33:492/659 of Q9NY91
- E457 (≠ A406) mutation to Q: Confers sugar transport activity not found in the wild-type protein. Increased sensitivity to inhibitor phlorizin.
3dh4A Crystal structure of sodium/sugar symporter with bound galactose from vibrio parahaemolyticus (see paper)
25% identity, 74% coverage: 72:435/494 of query aligns to 43:426/512 of 3dh4A
Sites not aligning to the query:
Q8N695 Sodium-coupled monocarboxylate transporter 1; Apical iodide transporter; Electrogenic sodium monocarboxylate cotransporter; Sodium iodide-related cotransporter; Solute carrier family 5 member 8 from Homo sapiens (Human) (see 3 papers)
24% identity, 73% coverage: 33:391/494 of query aligns to 43:401/610 of Q8N695
- V193 (≠ A191) to I: in dbSNP:rs1709189
- F251 (≠ M242) to V: in dbSNP:rs11834933
Sites not aligning to the query:
- 608 T→A: Loss of interaction with PDZK1.
- 608:610 PDZ-binding
- 610 L→A: Loss of interaction with PDZK1.
7wmvA Structure of human sglt1-map17 complex bound with lx2761 (see paper)
24% identity, 85% coverage: 12:431/494 of query aligns to 16:469/602 of 7wmvA
- binding N-[2-(dimethylamino)ethyl]-2-methyl-2-[4-[4-[[2-methyl-5-[(2S,3R,4R,5S,6R)-6-methylsulfanyl-3,4,5-tris(oxidanyl)oxan-2-yl]phenyl]methyl]phenyl]butanoylamino]propanamide: N61 (≠ D55), H66 (≠ L60), L70 (= L64), I81 (= I80), F84 (vs. gap), L257 (≠ M242), M266 (≠ Q251), L269 (≠ I254), T270 (≠ L255), Y273 (≠ F258), W274 (≠ M259), F436 (≠ L398), D437 (≠ G399), Q440 (≠ S402)
Sites not aligning to the query:
Q92911 Sodium/iodide cotransporter; Na(+)/I(-) cotransporter; Natrium iodide transporter; Sodium-iodide symporter; Na(+)/I(-) symporter; Solute carrier family 5 member 5 from Homo sapiens (Human) (see 3 papers)
23% identity, 74% coverage: 24:391/494 of query aligns to 36:403/643 of Q92911
- A102 (≠ W90) natural variant: A -> P
- H226 (≠ T214) mutation H->A,D,E,K: Significant loss of iodide transport activity but no effect on its localization to the cell membrane.
- D237 (≠ S225) mutation to A: Loss of localization to the cell membrane, significant loss of iodide transport activity but no effect on homodimerization.
- Y242 (≠ L230) Required for homodimerization; mutation to A: Loss of localization to the cell membrane, significant loss of iodide transport activity but no effect on homodimerization. Reduced homodimerization; when associated with A-471. Loss of iodide transport activity; when associated with F-535.
- T243 (≠ K231) Required for homodimerization; mutation to A: Loss of localization to the cell membrane, significant loss of iodide transport activity but no effect on homodimerization. Reduced homodimerization; when associated with A-471.
Sites not aligning to the query:
- 471 Required for homodimerization; Q→A: No effect on localization to the cell membrane, iodide transport activity and homodimerization. Significant loss of homodimerization; when associated with A-242 or A243.
- 525 A→F: Loss of localization to the cell membrane, significant loss of iodide transport activity but no effect on homodimerization. Loss of iodide transport activity; when associated with A-242.
- 536 T → Q: requires 2 nucleotide substitutions
- 556 S → Q: requires 2 nucleotide substitutions
8zqoA Human high-affinity choline transporter cht1 bound to hc-3 under nacl condition, with sodium and chloride ions coordinated. (see paper)
25% identity, 78% coverage: 8:390/494 of query aligns to 6:394/515 of 8zqoA
- binding chloride ion: G64 (≠ W59), W139 (≠ F137)
- binding (2S,2'S)-2,2'-biphenyl-4,4'-diylbis(2-hydroxy-4,4-dimethylmorpholin-4-ium): Y89 (≠ L82), W252 (≠ H253)
- binding sodium ion: A58 (= A53), T59 (≠ S54), T59 (≠ S54), V61 (≠ M56), G62 (≠ S57), D186 (= D187), A341 (= A337), S344 (= S340), S344 (= S340), S345 (≠ T341), D347 (≠ S343), S348 (≠ C344)
Sites not aligning to the query:
8j74A Human high-affinity choline transporter cht1 in the hc-3-bound outward-facing open conformation, dimeric state (see paper)
25% identity, 78% coverage: 8:390/494 of query aligns to 6:394/515 of 8j74A
- binding Lauryl Maltose Neopentyl Glycol: F203 (≠ I204), S206 (≠ L207), H207 (≠ A208), I213 (≠ T214), G214 (≠ T215), F215 (= F216), H219 (≠ E220), C326 (≠ F322), P327 (≠ N323)
- binding (2S,2'S)-2,2'-biphenyl-4,4'-diylbis(2-hydroxy-4,4-dimethylmorpholin-4-ium): W60 (≠ D55), Y89 (≠ L82), W139 (≠ F137), L245 (≠ W244), W252 (≠ H253)
Sites not aligning to the query:
Q9GZV3 High affinity choline transporter 1; hCHT1; Hemicholinium-3-sensitive choline transporter; CHT; Solute carrier family 5 member 7 from Homo sapiens (Human) (see 5 papers)
25% identity, 78% coverage: 8:390/494 of query aligns to 8:396/580 of Q9GZV3
- D48 (≠ S41) to G: in CMS20; decreased choline transmembrane transporter activity; no effect on localization at plasma membrane; dbSNP:rs886039768
- G65 (= G58) to E: in CMS20; loss of choline transmembrane transporter activity; no effect on localization at plasma membrane; dbSNP:rs886039765
- I89 (= I80) to V: 40% reduction in choline transmembrane transporter activity; found in 0.06 of Ashkenazi Jews; dbSNP:rs1013940; mutation to A: Decreased choline transmembrane transporter activity, only 20% of wild-type choline uptake activity.
- P105 (≠ R96) to S: in CMS20; decreased choline transmembrane transporter activity; no effect on localization at plasma membrane; dbSNP:rs886039766
- Y111 (≠ A107) to H: in CMS20; no effect on localization at plasma membrane
- Y175 (= Y174) to C: in CMS20; uncertain significance; dbSNP:rs1331713195
- I291 (= I293) to T: in CMS20; uncertain significance; dbSNP:rs375397889
- V344 (= V338) to L: in CMS20; uncertain significance
- R361 (≠ E355) to Q: in CMS20; decreased choline transmembrane transporter activity; no effect on localization at plasma membrane; dbSNP:rs147656110
Sites not aligning to the query:
- 418 F → V: in CMS20; uncertain significance
- 446 R → G: in CMS20; decreased choline transmembrane transporter activity; no effect on localization at plasma membrane
- 451 E→Q: Decreased choline transmembrane transporter activity, only 5% of wild-type choline uptake activity.
- 527:532 Dileucine-like motif
- 530 I→A: No change in protein internalization. No change in choline transmembrane transporter activity.
- 531 L→A: Loss of protein internalization to vesicular structures in neurons. Increased choline transmembrane transporter activity.
- 531:532 LV→AA: Decreased protein internalization; when associated with V-538. Increased choline transmembrane transporter activity; when associated with V-538.
- 532 V→A: Decreased protein internalization. Increased choline transmembrane transporter activity.
- 538 K→V: Decreased protein internalization; when associated with 531-L-V-532. Increased choline transmembrane transporter activity; when associated with 531-L-V-532.
8zqpA High affinity choline transporter 1 (see paper)
26% identity, 78% coverage: 8:390/494 of query aligns to 5:393/470 of 8zqpA
9bimA Cryo-em structure of human cht1 in the hc-3 bound outward-facing state (see paper)
25% identity, 78% coverage: 8:390/494 of query aligns to 7:393/516 of 9bimA
Sites not aligning to the query:
P11170 Sodium/glucose cotransporter 1; Na(+)/glucose cotransporter 1; High affinity sodium-glucose cotransporter; Solute carrier family 5 member 1 from Oryctolagus cuniculus (Rabbit) (see 2 papers)
31% identity, 38% coverage: 12:201/494 of query aligns to 33:219/662 of P11170
Sites not aligning to the query:
- 255 modified: Disulfide link with 608
- 457 Q→W: Drasticly decreased affinity for glucose and phlorizin.
- 460 T→W: Decreased affinity for glucose and phlorizin.
- 608 modified: Disulfide link with 255
7sl9A Cryoem structure of smct1 (see paper)
24% identity, 80% coverage: 41:437/494 of query aligns to 30:428/497 of 7sl9A
7slaA Cryoem structure of sglt1 at 3.15 angstrom resolution (see paper)
23% identity, 74% coverage: 66:430/494 of query aligns to 49:454/585 of 7slaA
Sites not aligning to the query:
7sl8A Cryoem structure of sglt1 at 3.4 a resolution (see paper)
23% identity, 74% coverage: 66:430/494 of query aligns to 48:453/582 of 7sl8A
Sites not aligning to the query:
8hdhA Structure of human sglt2-map17 complex with canagliflozin (see paper)
25% identity, 76% coverage: 4:376/494 of query aligns to 1:407/586 of 8hdhA
- binding (2~{S},3~{R},4~{R},5~{S},6~{R})-2-[3-[[5-(4-fluorophenyl)thiophen-2-yl]methyl]-4-methyl-phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol: N55 (≠ D55), G59 (≠ W59), H60 (≠ L60), G63 (= G63), L64 (= L64), F78 (vs. gap), E79 (vs. gap), S267 (≠ M242), W271 (≠ F249)
- binding sodium ion: A53 (= A53), S54 (= S54), I56 (≠ M56), G57 (≠ S57), A369 (= A337), S372 (= S340), S373 (≠ T341)
Sites not aligning to the query:
- binding (2~{S},3~{R},4~{R},5~{S},6~{R})-2-[3-[[5-(4-fluorophenyl)thiophen-2-yl]methyl]-4-methyl-phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol: 433, 434, 437, 506
- binding : 575, 579, 580, 583, 584
8hb0A Structure of human sglt2-map17 complex with ta1887 (see paper)
25% identity, 76% coverage: 4:376/494 of query aligns to 1:407/586 of 8hb0A
- binding (2R,3R,4S,5S,6R)-2-[3-[(4-cyclopropylphenyl)methyl]-4-fluoranyl-indol-1-yl]-6-(hydroxymethyl)oxane-3,4,5-triol: N55 (≠ D55), H60 (≠ L60), G63 (= G63), L64 (= L64), T67 (≠ A67), V75 (≠ E75), F78 (vs. gap), E79 (vs. gap), V137 (≠ S143), V266 (≠ L241), S267 (≠ M242), W271 (≠ F249)
- binding sodium ion: A53 (= A53), I56 (≠ M56), G57 (≠ S57), A369 (= A337), S372 (= S340), S373 (≠ T341)
Sites not aligning to the query:
- binding (2R,3R,4S,5S,6R)-2-[3-[(4-cyclopropylphenyl)methyl]-4-fluoranyl-indol-1-yl]-6-(hydroxymethyl)oxane-3,4,5-triol: 433, 437
- binding : 575, 576, 579, 580, 583, 584
P31639 Sodium/glucose cotransporter 2; Na(+)/glucose cotransporter 2; Low affinity sodium-glucose cotransporter; Solute carrier family 5 member 2 from Homo sapiens (Human) (see 2 papers)
25% identity, 76% coverage: 3:376/494 of query aligns to 20:427/672 of P31639
- A73 (= A53) binding Na(+)
- S74 (= S54) mutation to A: Impairs phlorizin binding and its inhibition on glucose uptake.
- I76 (≠ M56) binding Na(+)
- V95 (≠ E75) mutation to I: Strong reduction in D-glucose transporter activity. Impairs inhibition by empagliflozin on glucose uptake.
- F98 (vs. gap) mutation to A: Slightly decreases D-glucose transporter activity. Abolishes empagliflozin binding and its inhibition on glucose uptake. Impairs phlorizin binding and its inhibition on glucose uptake.
- V157 (≠ S143) mutation to A: Decreases D-glucose transporter activity. Impairs inhibition by empagliflozin on glucose uptake.
- D201 (= D187) mutation to A: Impairs phlorizin binding and its inhibition on glucose uptake.
- L283 (≠ I238) mutation to M: Strong reduction in D-glucose transporter activity. Impairs inhibition by empagliflozin on glucose uptake.
- A389 (= A337) binding Na(+)
- S392 (= S340) binding Na(+)
- S393 (≠ T341) binding Na(+)
Sites not aligning to the query:
- 453 F→A: Slightly decreases D-glucose transporter activity. Impairs empagliflozin binding and its inhibition on glucose uptake. Impairs phlorizin binding and its inhibition on glucose uptake.
8hg7A Structure of human sglt2-map17 complex with sotagliflozin (see paper)
25% identity, 76% coverage: 4:376/494 of query aligns to 1:407/590 of 8hg7A
- binding (2S,3R,4R,5S,6R)-2-[4-chloranyl-3-[(4-ethoxyphenyl)methyl]phenyl]-6-methylsulfanyl-oxane-3,4,5-triol: N55 (≠ D55), G59 (≠ W59), H60 (≠ L60), G63 (= G63), L64 (= L64), E79 (vs. gap), V266 (≠ L241), S267 (≠ M242), Y270 (= Y248), W271 (≠ F249), K301 (≠ T285)
- binding sodium ion: A53 (= A53), S54 (= S54), I56 (≠ M56), G57 (≠ S57), A369 (= A337), S372 (= S340), S373 (≠ T341)
Sites not aligning to the query:
- binding (2S,3R,4R,5S,6R)-2-[4-chloranyl-3-[(4-ethoxyphenyl)methyl]phenyl]-6-methylsulfanyl-oxane-3,4,5-triol: 433, 437
- binding : 579, 583, 584, 587, 588
Query Sequence
>AO356_09010 FitnessBrowser__pseudo5_N2C3_1:AO356_09010
MSVSNPTLITFVIYIAAMVLIGLMAYRSTNNLSDYILGGRSLGSVVTALSAGASDMSGWL
LMGLPGAIYMSGLSESWIAIGLIVGAYLNWLFVAGRLRVQTEHNGDALTLPDYFSSRFED
KSGLLRIISAVVILVFFTIYCASGIVAGARLFESTFGMSYETALWAGAAATIAYTFVGGF
LAVSWTDTVQATLMIFALILTPIIVLLATGGVDTTFLAIEAKDPSSFDMLKNTTFIGIIS
LMGWGLGYFGQPHILARFMAADSVKSIANARRISMTWMILCLGGTVAVGFFGIAYFSAHP
DVAGPVTENPERVFIELAKLLFNPWIAGVLLSAILAAVMSTLSCQLLVCSSALTEDFYKT
FLRKSASQLELVWVGRAMVLLVALVAIALAANPENRVLGLVSYAWAGFGAAFGPVVLISV
IWKNMTRNGALAGILVGAITVIVWKHFALLGLYEIIPGFIFASLAIYLVSKMGSPTAGML
QRFDAAEKDFRLNQ
Or try a new SitesBLAST search
SitesBLAST's Database
SitesBLAST's database includes
(1) SwissProt
entries with experimentally-supported functional features;
and (2) protein structures with bound ligands, from the
BioLip database.
by Morgan Price,
Arkin group
Lawrence Berkeley National Laboratory